2006; 17: 167-71. 1277. VISCOMI S, PASTORE G, MOSSO ML, TERRACINI B, MADON E, MAGNANI C, MERLETTI F; CHILDHOOD CANCER REGISTRY OF PIEDMONT, ITALY. Population-based survival after childhood cancer diagnosed during 1970-98: a report from the Childhood Cancer Registry of Piedmont, Italy. Haematologica 2003; 88: 974-82. 1278. VITOLO U, LIBERATI AM, CABRAS MG, FEDERICO M, ANGELUCCI E, BALDINI L, BOCCOMINI C, BRUGIATELLI M, CALVI R, CICCONE G, GENUA A, DELILIERS GL, LEVIS A, PARVIS G, PAVONE E, SALVI F, SBORGIA M, GALLO E; Intergruppo Italiano Linfomi. High dose sequential chemotherapy with autologous transplantation versus dose-dense chemotherapy MegaCEOP as first line treatment in poor-prognosis diffuse large cell lymphoma: an "Intergruppo Italiano Linfomi" randomized trial. Haematologica 2005; 90: 793-801. 1279. VITOLO U, ROSSI G, CABRAS MG, LIBERATI AM, CHIAPPELLA A, LEVIS A, PAVONE E, ANGELUCCI E, BOTTO B, CECCARELLI M, FREILONE R, GAIDANO G, NOVERO D, ORSUCCI L, PALUMBO I, POGLIANI E, ROTA SCALABRINI D, SALVI F, TONSO A, TUCCI A, AND GALLO E. Effect Of Adding Rituximab (R) To Induction Treatment And High Dose Chemotherapy (HDC) Prior To Autologous Stem Cell Transplantation (ASCT) As First Line Therapy In Stage III-IV Diffuse Large B-Cell Lymphoma (B-DLCL) At Poor Prognosis. Blood 2005; 106: 676. 1280. VITOLO U, ROSSI G, CABRAS MG, LIBERATI AM, CHIAPPELLA A, LEVIS A, PAVONE E, ANGELUCCI E, BOTTO B, CICCONE G, FREILONE R, NOVERO D, ORSUCCI L, PALUMBO I, POGLIANI E, PREGNO P, ROTA-SCALABRINI D, SALVI F, TONSO A, TUCCI A AND GALLO E. Effect Of Adding Rituximab (R) To Intensified And High Dose Chemotherapy (HDC) With Asct As First Line Treatment In Stage III-IV At Intermediate-High (IH) And High (H) Risk Diffuse Large B-Cell Lymphoma (B-DLCL). Haematologica 2005; 90 (supplement 3); P537. 1281. VOLANTE R, GIUBILATO P, RONCO G. Quality of colposcopy and treatment: data from the national survey of Italian organised cervical screening programmes. Epidemiol Prev 2008; 32: 69-76. 1282. VOLANTE R, GIUBILATO P, RONCO G. Quality of colposcopy and treatment: data from the national survey of Italian organised cervical screening programmes. Epidemiol Prev 2007; 31: 61-8. 1283. VOLANTE R, RONCO G. National survey of the quality of 2nd level in screening for cervical cancer. Epidemiol Prev 2006; 30: 51-7. 1284. VOLLSET SE, IGLAND J, JENAB M, FREDRIKSEN A, MEYER K, EUSSEN S, GJESSING HK, UELAND PM, PERA G, SALA N, AGUDO A, CAPELLA G, DEL GIUDICE G, PALLI D, BOEING H, WEIKERT C, BUENO-DE-MESQUITA HB, CARNEIRO F, PALA V, VINEIS P, TUMINO R, PANICO S, BERGLUND G, MANJER J, STENLING R, HALLMANS G, MARTÍNEZ C, DORRONSORO M, BARRICARTE A, NAVARRO C, QUIRÓS JR, ALLEN N, KEY TJ, BINGHAM S, LINSEISEN J, KAAKS R, OVERVAD K, TJØNNELAND A, BÜCHNER FL, PEETERS PH, NUMANS ME, CLAVEL-CHAPELON F, BOUTRON-RUAULT MC, TRICHOPOULOU A, LUND E, SLIMANI N, FERRARI P, RIBOLI E, GONZÁLEZ CA. The association of gastric cancer risk with plasma folate, cobalamin, and methylenetetrahydrofolate reductase polymorphisms in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 2007; 16: 2416-24. 1285. VON KARSA L, ANTTILA A, RONCO G, PONTI A, MALILA N, ARBYN M, SEGNAN N, CASTILLO-BELTRAN M, BONIOL M, FERLAY J, HERY C, SAUVAGET C, VOTI L, AUTIER P. Cancer screening in the European Union. Report on the implementation of the council recommendation of cancer screening. First report. European Commission. Luxembourg, 2008. 1286. WANG SS, SLAGER SL, BRENNAN P, HOLLY EA, DE SANJOSE S, BERNSTEIN L, BOFFETTA P, CERHAN JR, MAYNADIE M, SPINELLI JJ, CHIU BC, COCCO PL, MENSAH F, ZHANG Y, NIETERS A, <strong>DAL</strong> MASO L, BRACCI PM, COSTANTINI AS, VINEIS P, SEVERSON RK, ROMAN E, COZEN W, WEISENBURGER D, DAVIS S, FRANCESCHI S, LA VECCHIA C, FORETOVA L, BECKER N, STAINES A, VORNANEN M, ZHENG T, HARTGE P. Family history of hematopoietic malignancies and risk of non- Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph). Blood 2007; 109: 3479-88. 1287. WECHSLER J, ZANETTI R, SCHRAMECK C, ROSSO S, PIPPIONE M, LINARES J, LAURENT R, ORTUNO G, BOI S, GAFA L, JORIS F, SPATZ A, BARNEON G, SACERDOTE C, SANCHO-GARNIER H. Reproducibility of histopathologic diagnosis and classification of non-melanocytic skin cancer: a panel exercise in the framework of the multicenter southern European study HELIOS. Tumori 2001; 87: 95-100. 1288. WEIKERT S, BOEING H, PISCHON T, OLSEN A, TJONNELAND A, OVERVAD K, BECKER N, LINSEISEN J, LAHMANN PH, ARVANITI A, KASSAPA C, TRICHOUPOULOU A, SIERI S, PALLI D, TUMINO R, VINEIS P, PANICO S, VAN GILS CH, PEETERS PH, BUENO-DE-MESQUITA HB, BUCHNER FL, LJUNGBERG B, HALLMANS G, BERGLUND G, WIRFALT E, PERA G, DORRONSORO M, GURREA AB, NAVARRO C, MARTINEZ C, QUIROS JR, ALLEN N, RODDAM A, BINGHAM S, JENAB M, 80
SLIMANI N, NORAT T, RIBOLI E. Fruits and vegetables and renal cell carcinoma: Findings from the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer 2006; 118: 3133-9. 1289. WÜNSCH-FILHO V, MONCAU JE, MIRABELLI D, BOFFETTA P. Occupational risk factors of lung cancer in São Paulo, Brazil. Scand J Work Environ Health 1998; 24: 118-24. 1290. ZAMBELLI S, ZANIN A, GAGLIO A, ZAI G, BOSCO E, ANDRION A, MAGNANI C. Ki-67 scores and AgNor counts in transitional cell carcinoma of the bladder: apparent lack of prognostic value. Arch It Urol <strong>1993</strong>; LXV: 665- 70. 1291. ZANETTI R, BUIATTI E, FEDERICO M, MICHELI A. Fatti e cifre dei tumori in Italia. Il pensiero Scientifico Editore. Roma 1998. 1292. ZANETTI R, CROSIGNANI P, ROSSO S. Il Cancro in Italia. I dati di incidenza dei Registri Tumori: 1988-1992. Il Pensiero Scientifico Editore, 1997. 1293. ZANETTI R, FALCINI F, SIMONATO L, VERCELLI M. [Survival of cancer patients in Italy in the nineties: the importance of population based data.] Epidemiol Prev 2001; 25: 1-8. 1294. ZANETTI R, FERRETTI S, FUSCO M, BELLU’ F, RAMAZZOTTI V, CROSIGNANI P, & GRUPPO AIRT. L’incidenza del cancro in Italia alla metà degli anni ‘90. In: Zanetti R, Gafà L, Pannelli F, Conti E, Rosso S, eds, Il Cancro in Italia. I dati di incidenza dei Registri Tumori. Volume terzo: <strong>1993</strong>-1998. Il Pensiero Scientifico Editore, Roma 2002. 1295. ZANETTI R, GAFÀ L, FRANCESCHI S, ROSSO S. Stima della proporzione di tumori cutanei attribuibili all'esposizione solare in tre popolazioni italiane. Epidemiol Prev 1999; 23: 416-22. 1296. ZANETTI R, GAFA’ L, PANNELLI F, CONTI E, ROSSO S. Il Cancro in Italia. I dati di incidenza dei Registri Tumori. Volume terzo: <strong>1993</strong>-1998. Il Pensiero Scientifico Editore, Roma 2002. 1297. ZANETTI R, GIACOMIN A. Urinary tract cancers: kidney and urinary bladder. Epidemiol Prev 2004; 28: 82-7. 1298. ZANETTI R, LORIA D, ROSSO S. Melanoma, Parkinson's disease and levodopa: causal or spurious link A review of the literature. Melanoma Res 2006; 16: 201-6. 1299. ZANETTI R, MICHELI A, ROSSO S, SANT M. The prevalence of cancer: a review of the available data. Tumori 1999; 85: 408-13. 1300. ZANETTI R, PONTI A, ROSSO S, RICCERI F, PITARELLA S, SEGNAN N. The beginning of a decline in breast cancer incidence in Italy Tumori 2008; 94: 293-6. (IF 0.597) 1301. ZANETTI R, PROTA G, NAPOLITANO A, MARTINEZ C, SANCHO-GARNIER H, OSTERLIND A, SACERDOTE C, ROSSO S. Development of an integrated method of skin phenotype measurement using the melanins. Melanoma Res 2001; 11: 551-7. 1302. ZANETTI R, ROSSO S, LORIA DI. Parkinson's disease and cancer. Cancer Epidemiol Biomarkers Prev 2007; 16: 1081. 1303. ZANETTI R, ROSSO S, MARTINEZ C, NAVARRO C, SCHRAUB S, SANCHO-GARNIER H, FRANCESCHI S, GAFÀ L, PEREA E, TORMO MJ, LAURENT R, SCHRAMECK C, CRISTOFOLINI M, TUMINO R, WECHSLER J. The multicentre south-european study "HELIOS": I. Skin characteristics and sunburns in basal cell and squamous cell carcinomas of the skin. Br J Cancer 1996; 73: 1440-6. 1304. ZANETTI R, ROSSO S, MARTINEZ C, NIETO A, MIRANDA A, MERCIER M, LORIA DI, OSTERLIND A, GREINERT R, NAVARRO C, FABBROCINI G, BARBERA C, SANCHO-GARNIER H, GAFA L, CHIARUGI A, MOSSOTTI R. Comparison of risk patterns in carcinoma and melanoma of the skin in men: a multi-centre case-case-control study. Br J Cancer 2006; 94: 743-51. 1305. ZANETTI R, ROSSO S, NAVARRO C, SANCHO-GARNIER H, MARTINEZ C, SCHRAUB S, FRANCESCHI S, GAFA' L, WECHSLER J. The multicentre south european study "Helios" Different exposure pattern between basal-cell carcinoma and squamous-cell carcinoma of the skin. Atti de "XVIII Réunion du Groupe pour l'Epidemiologie et l'Enregistrement du Cancer dans le Pays de Langue Latine. Dijon". IARC Technical Report N° 20, Lyon, <strong>1993</strong>. 1306. ZANETTI R, ROSSO S, PROTA G, NAPOLITANO A, SNACHO-GARNIER H, MARTINEZ C, ØSTERLIND A, KOLOMOETS E. Prevention of melanoma and non-melanocytic skin cancer development of a new method for high risk groups detection. Pilot phase: final report. Europe Against Cancer Programme: Technical Report. 81
- Page 1 and 2:
Centro di Riferimento per l’Epide
- Page 3 and 4:
26. ALESSI D, PASTORE G, BAGNATI R,
- Page 5 and 6:
as much screening as women
- Page 7 and 8:
86. BEDESCHI E, CAMPARI C, CANDELA
- Page 9 and 10:
120. BIGGERI A, STANGHELLINI E, MER
- Page 11 and 12:
151. BO S, CICCONE G, ROSATO R, GAN
- Page 13 and 14:
181. BOYLE P, VAINIO H, SMITH R, BE
- Page 15 and 16:
211. BRUNO G, MERLETTI F, BOFFETTA
- Page 17 and 18:
243. CARNINO F, FUDA G, CICCONE G,
- Page 19 and 20:
276. CICCONE G, PRASTARO C, IVALDI
- Page 21 and 22:
308. CUCCORESE C, MANO M.P, PONTI A
- Page 23 and 24:
331. DANESH J, SARACCI R, BERGLUND
- Page 25 and 26:
362. DREASSI E, LAGAZIO C, MAULE MM
- Page 27 and 28:
393. FERREYRA GP, BAUSSANO I, SQUAD
- Page 29 and 30: 427. GEHRING U, PATTENDEN S, SLACHT
- Page 31 and 32: ecruitment phase of a large randomi
- Page 33 and 34: 489. GREGORI D, MORRA B, SNIDERO S,
- Page 35 and 36: 524. IOANNIDIS JP, BERNSTEIN J, BOF
- Page 37 and 38: 546. KAUPPINEN T, TOIKKANEN J, PEDE
- Page 39 and 40: 568. LINSEISEN J, ROHRMANN S, NORAT
- Page 41 and 42: 601. MAGNANI C, TERRACINI B, IVALDI
- Page 43 and 44: 633. MASALA G, DI LOLLO S, PICOCO C
- Page 45 and 46: 669. MERLETTI F, MIRABELLI D. Espos
- Page 47 and 48: 706. MIRABELLI D, CADUM E. [Mortali
- Page 49 and 50: BERGMANN MM, OVERVAD K, BOUTRON-RUA
- Page 51 and 52: 774. PAGANO E. Come è difficile tr
- Page 53 and 54: 803. PASTORE G, MOSSO ML, MAGNANI C
- Page 55 and 56: 836. PINAMONTI B, PERKAN A, DI LENA
- Page 57 and 58: 864. PONTI A, SEGNAN N, BLAMEY R, B
- Page 59 and 60: 897. RICHIARDI L, BOFFETTA P, MERLE
- Page 61 and 62: comparing human papillomavirus test
- Page 63 and 64: 958. ROSSO S AND THE AIRTUM WORKING
- Page 65 and 66: 995. SANT M, ALLEMANI C, DE ANGELIS
- Page 67 and 68: 1026. SEGNAN N, SENORE C, GIORDANO
- Page 69 and 70: European Prospective Investigation
- Page 71 and 72: 1089. 'T MANNETJE A, KOGEVINAS M, C
- Page 73 and 74: 1136. TERRACINI B. When and why can
- Page 75 and 76: 1165. VELTRI A, GARETTO I, PAGANO E
- Page 77 and 78: 1200. VINEIS P, MALATS N, PORTA M,
- Page 79: 1247. VINEIS P. Evidence-based prim
- Page 83: 1327. ZUCCOLO L, PASTORE G, PEARCE